🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,136 results for “The First People's Hospital of Lianyungang” Clear

  1. 2 cycles induction chemotherapy

    The First People's Hospital of Lianyungang

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  2. 20 mg sildenafil citrate by mouth

    The First People's Hospital of Lianyungang

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  3. 3-N-butylphthalide

    The First People's Hospital of Lianyungang

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  4. 6-month course of antiandrogen drugs

    The First People's Hospital of Lianyungang

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    phase 3 small molecule active

    1 trial

  5. AZVUDINE

    The First People's Hospital of Lianyungang

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  6. Acetazolamide Levamisole

    The First People's Hospital of Lianyungang

    HCC

    phase 3 small molecule active

    1 trial

  7. Aerobic Exercise

    The First People's Hospital of Lianyungang

    Primary Hypertension

    phase 3 other active

    1 trial

  8. Alirocumab

    The First People's Hospital of Lianyungang

    Intracranial Atherosclerosis

    phase 3 small molecule active

    1 trial

  9. Amlodipine

    The First People's Hospital of Lianyungang

    Sleep Apnea Syndrome

    phase 3 small molecule active

    1 trial

  10. Azacitidine Combined With Venetoclax and ATRA group

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  11. Azathioprine

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  12. Bedaquiline (B)

    The First People's Hospital of Lianyungang

    Pulmonary Tuberculosis

    phase 3 small molecule active

    1 trial

  13. Botulinum Toxin type A (intradermal / submucosal injection at pain area)

    The First People's Hospital of Lianyungang

    Trigeminal Neuralgia

    phase 3 small molecule active

    1 trial

  14. Busulfan (BU)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma

    phase 3 small molecule active

    1 trial

  15. Camrelizumab

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 small molecule active

    2 trials

  16. Capecitabine monotherapy

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 3 small molecule active

    1 trial

  17. Capecitabine(Aibin)

    The First People's Hospital of Lianyungang

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  18. Chemotherapy

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia

    phase 3 small molecule completed

    1 trial

  19. Chemotherapy

    The First People's Hospital of Lianyungang

    Endometrial Cancer

    phase 3 small molecule active

    1 trial

  20. Clamp-Crushing technique

    The First People's Hospital of Lianyungang

    Hepatobiliary Disease

    phase 3 other completed

    1 trial

  21. Continuous Gastrocnemius plane block with ropivacaine

    The First People's Hospital of Lianyungang

    Foot Ankle Injuries

    phase 3 small molecule active

    1 trial

  22. Crystalline cellulose simple occlusive dressing

    The First People's Hospital of Lianyungang

    Split-thickness Skin Graft Donor Sites

    phase 3 other completed

    1 trial

  23. Cytarabine

    The First People's Hospital of Lianyungang

    Leukemia

    phase 3 small molecule active

    1 trial

  24. Decitabine

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources